Results from a huge epidemiological study found that infection by the Epstein-Barr virus increases the risk of developing multiple sclerosis 32-fold. This result, combined with emerging mechanistic insights into how the virus triggers brain damage, are raising the prospect of treating or preventing MS.
These advances come at a time when researchers are more interested than ever in what happens in the months and years following a viral infection, and highlights the issues untangling the relationships between infectious diseases and chronic conditions.
This is an audio version of our Feature: The quest to prevent MS — and understand other post-viral diseases.
Never miss an episode: Subscribe to the Nature Podcast on Apple Podcasts, Google Podcasts, Spotify or your favourite podcast app. Head here for the Nature Podcast RSS feed
Long COVID’s long R&D agenda
The four most urgent questions about long COVID
Pandemics disable people — the history lesson that policymakers ignore
